TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Co-Infection
Researchers at University of Milan have published new data on HIV/AIDS co-infection
September 23rd, 2008
According to recent research from Milan, Italy, "An immune response mediated by type 2 cytokines is thought to contribute to the development and unfavorable outcome of aspergillosis." "Adjuvant therapy with interferon-gamma (IFN-gamma) and granulocyte-macrophage colony stimulating factor (GM-CSF) was added to antifungal treatment in three nonneutropenic patients (one HIV-positive and two HIV-negative patients) with culture proven aspergillosis refractory to classical antifungal therapy. Clinical improvement was observed concomitantly with an increase in peripheral blood Leukocyte proliferation and type 1 cytokines production," wrote A. Bandera and colleagues, University...
Source: TB & Outbreaks Week (2008-09-23)
|
